Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Oligodendroglioma 2Lymphoma 2Lung Neoplasms 2Hodgkin Disease 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Astrocytoma 2Recurrence 1Optic Nerve Glioma 1Neurofibromatosis 1 1Neoplasm Metastasis 1Melanoma 1Kidney Neoplasms 1Hematologic Diseases 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Brain Neoplasms 1

Interventions

Filgrastim 8Temozolomide 6Carboplatin 6Granulocyte Colony-Stimulating Factor 4Etoposide 4O(6)-benzylguanine 3Busulfan 3Vorinostat 2Topotecan 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Irinotecan 2Ifosfamide 2Cyclophosphamide 2veliparib 1trioctyl phosphine oxide 1sodium thiosulfate 1sargramostim 1romidepsin 1pomalidomide 1pazopanib 1lonafarnib 1laromustine 1ixabepilone 1ispinesib 1imetelstat 1exatecan 1etoposide phosphate 1emvododstat 1cediranib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Optic Nerve Glioma × Vinblastine × Clear all
NCT00352495 2014-02-13

Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

Children's Oncology Group

Phase 1 Completed
26 enrolled
CNS

Astrocytoma, Neurofibromatosis 1, Oligodendroglioma, Central Nervous System Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡